TTM
−$8.15
YoY change
-21.7%
5Y CAGR
—
Peak year (2021)
$28.29
Latest annual
−$7.26
EPS (Diluted) history chart for Moderna (MRNA) from 2016 to 2025
Latest: −$7.26
EPS (Diluted) growth chart for Moderna (MRNA) from 2016 to 2025
Latest: -21.7%
EPS (Diluted) history table for Moderna (MRNA) from 2016 to 2025
| 2025 | −$7.26 | -21.7% | +$2.01 | ||
| 2024 | −$9.27 | -24.9% | +$3.07 | ||
| 2023 | −$12.34 | -161.4% | −$32.44 | ||
| 2022 | $20.10 | -29.0% | −$8.19 | ||
| 2021 | $28.29 | -1543.4% | +$30.25 | ||
| 2020 | −$1.96 | +26.5% | −$0.41 | ||
| 2019 | −$1.55 | +32.5% | −$0.38 | ||
| 2018 | −$1.17 | +62.5% | −$0.45 | ||
| 2017 | −$0.72 | -81.0% | +$3.07 | ||
| 2016 | −$3.79 | — | — |
- 2025−$7.26-21.7%
- 2024−$9.27-24.9%
- 2023−$12.34-161.4%
- 2022$20.10-29.0%
- 2021$28.29-1543.4%
- 2020−$1.96+26.5%
- 2019−$1.55+32.5%
- 2018−$1.17+62.5%
- 2017−$0.72-81.0%
- 2016−$3.79—
EPS (Diluted) values are taken from Moderna's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About EPS (Diluted) at Moderna (MRNA)
According to Moderna's latest reported financial statements, the company's current diluted EPS (TTM) is −$8.15. Diluted earnings per share (EPS) is net income divided by the diluted weighted-average shares outstanding over the period. It expresses profit on a per-share basis — the figure investors use to value an individual share — and accounts for potential dilution from options, RSUs, and convertible securities.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Moderna (MRNA) most recent annual diluted EPS stands at −$7.26 (2025) – declined 21.7% year-over-year.
Moderna diluted EPS plunged from $28.29 in 2021 to −$7.26 in 2025, a 125.7% drawdown.
$28.29 stands as the all-time-high annual diluted EPS, posted in 2021, against a low of −$12.34 during 2023.
Moderna EPS (Diluted) by Year
Moderna EPS (Diluted) 2025: −$7.26
2025's diluted EPS for Moderna came in at −$7.26, declined 21.7% below 2024.
Moderna EPS (Diluted) 2024: −$9.27
Moderna posted diluted EPS of −$9.27 in 2024, declined 24.9% below 2023.
Moderna EPS (Diluted) 2023: −$12.34
In 2023, Moderna reported diluted EPS of −$12.34, plunged 161.4% below 2022. This figure represents the lowest annual value in the available history.
Moderna EPS (Diluted) 2022: $20.10
Moderna diluted EPS in 2022 was $20.10, declined 29.0% below 2021.
Moderna EPS (Diluted) 2021: $28.29
Moderna diluted EPS in 2021 was $28.29.
See more financial history for Moderna (MRNA). Or calculate EPS yourself.
Sector peers by EPS (Diluted)
Healthcare peers of Moderna (MRNA), ranked by their latest diluted EPS
| $22.95 | |
| $14.23 | |
| $13.23 | |
| $11.03 | |
| $7.28 | |
| $6.54 | |
| $3.59 | |
| $2.37 |
- $22.95
- $14.23
- $13.23
- $11.03
- $7.28
- $6.54
- $3.59
- $2.37
Frequently asked questions
Moderna (MRNA) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation